Great to see some increased interest. From my understanding Manny has been putting on his world class roadshow with eSVS Mesh in tow. Most recent sighting in South Florida. I always like a brilliant and scrappy CEO, still a believer here at $0.76 cents and $20.5mm cap.
Great to hear from you, I always value your insights on YMB. I firmly agree that KIPS is unlikely to issue 90mm, in fact I don't think we see anything close to that. I want to correct you on one thing, KIPS has enough cash on hand to get through 3rd or 4th quarter this year; however, management is very responsible and will likely take the necessary steps to shore up by March 31st... your estimate of $20-30mm is far too high. I believe $4-5mm will be more than enough to see eSVS well through feasibility (my estimation to be completed w/ follow up angiograms by 4th quarter 2014).
As mentioned, I do not expect a public offering here at $0.71. I am of the opinion that we see a tactful private placement done with a strategic investor who understands the potential of eSVS Mesh and is willing to take an active role. Keep the discussion coming!
An expected YMB response hidden behind an alias... I do not expect institutional interest here at these levels; however, I do imagine that if I wanted a good chunk (around $5,000,000) of KIPS I would be willing to buy at $1+, a share purchase of this size made in the open market would likely send this flying well north of $1.
I do not believe that we will see the 90mm used. Keep in mind that this is only an option for management to offer additional shares. In my humble opinion, KIPS is very unlikely to do a public offering; however, I would not be surprised to see a strategic private placement done above market ($1+) to throw cash in the vault and ensure the time needed to complete feasibility. This would be a favorable dilution in my opinion and warrant a positive response from investors.
I highly doubt that we will see Manny use even close to the full 90, and I for one don't mind giving them a bit of wiggle room. It takes cash to get through feasibility studies. Long and strong here at $0.70, expecting a favorable private placement and FDA enrollment expansion response in the coming weeks/months.
I am of the opinion that once the headwinds have subsided, investors will be pilling in. Feasibility study (implants and angiograms) likely to be completed come 4th quarter 2014. ESVS is truly unique and has billion $ revenue potential. With the balance sheet shored up, watch for analyst coverage and increased institutional interest. There are deep pockets behind KIPS in the form of active shareholders. One could wait for smooth sailing; however, by then we will likely be in the $2.50-$5.00 range. January 2014 and $0.70 is the time to load up.